Literature DB >> 19205619

Significance of survivin, caspase-3, and VEGF expression in thyroid carcinoma.

Hai-Yan Zhang1, Xin Meng, Zhen-Xian Du, Chang-Qing Fang, Guo-Liang Liu, Hua-Qin Wang, Wei-Wei Deng.   

Abstract

To investigate the clinical significance of survivin, caspase-3, and vascular endothelial growth factor expression in a subset of thyroid carcinoma and their correlation with prognosis. Sixty-eight cases of thyroid carcinoma (TC), 12 cases of thyroid adenoma (TA) and 10 cases of normal thyroid tissue (NT) were involved in immunohistochemical and real-time RT-PCR analyses for survivin, caspase-3, and VEGF expression. Statistical analyses were performed for differential expression among NT, TA and TC, correlations of their expression with the clinicopathological parameters of TC including histological typing, clinical staging and lymphnode metastasis, and relationship of survivin with caspase-3 or VEGF in TC. We observed higher mRNA expression and positive immunostaining for survivin and VEGF in TC compared with TA and NT, with a significant positive correlation among them and significant correlations with histological typing, clinical staging and lymphnode metastasis in TC, but we could not find any significance of caspase-3 in TC and its significant relationship with survivin expression. Our results indicate that survivin and VEGF are unfavorable molecules for TC evolution and prognosis, and possess positive correlation in TC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205619     DOI: 10.1007/s10238-009-0031-7

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  26 in total

1.  Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease.

Authors:  F Farina; F Cappello; M Todaro; F Bucchieri; G Peri; G Zummo; G Stassi
Journal:  J Histochem Cytochem       Date:  2000-01       Impact factor: 2.479

2.  Downregulation of survivin is associated with reductions in TNF receptors' mRNA and protein and alterations in nuclear factor kappa B signaling in urothelial cancer cells.

Authors:  Bayan T Takizawa; Edward M Uchio; Justin J Cohen; Marcia A Wheeler; Robert M Weiss
Journal:  Cancer Invest       Date:  2007-12       Impact factor: 2.176

3.  Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.

Authors:  Iwona Lewy-Trenda; Agnieszka Wierzchniewska-Ławska
Journal:  Pol J Pathol       Date:  2002       Impact factor: 1.072

4.  Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop.

Authors:  Joaquim Miguel Vieira; Susana C Rosa Santos; Carla Espadinha; Isabel Correia; Tibor Vag; Cristina Casalou; Branca Maria Cavaco; Ana Luiísa Catarino; Sérgio Dias; Valeriano Leite
Journal:  Eur J Endocrinol       Date:  2005-11       Impact factor: 6.664

5.  Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.

Authors:  Ellen J Schlette; L Jeffrey Medeiros; Andre Goy; Raymond Lai; George Z Rassidakis
Journal:  J Clin Oncol       Date:  2004-05-01       Impact factor: 44.544

6.  Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.

Authors:  Aziza Nassar; Diane Lawson; George Cotsonis; Cynthia Cohen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2008-03

7.  Paneling human thyroid cancer cell lines for candidate proteins for targeted anti-angiogenic therapy.

Authors:  Sebastian Hoffmann; Anette Wunderlich; Ilhan Celik; Katja Maschuw; Iyad Hassan; Lorenz C Hofbauer; Andreas Zielke
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

8.  Increased apoptosis accompanies neoplastic development in the human colorectum.

Authors:  F A Sinicrope; G Roddey; T J McDonnell; Y Shen; K R Cleary; L C Stephens
Journal:  Clin Cancer Res       Date:  1996-12       Impact factor: 12.531

9.  The role of survivin in angiogenesis during zebrafish embryonic development.

Authors:  Alvin Ch Ma; Rachel Lin; Po-Kwok Chan; Joseph C K Leung; Loretta Y Y Chan; Anming Meng; Catherine M Verfaillie; Raymond Liang; Anskar Y H Leung
Journal:  BMC Dev Biol       Date:  2007-05-18       Impact factor: 1.978

10.  Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.

Authors:  M-H Malcles; H-W Wang; A Koumi; Y-H Tsai; M Yu; A Godfrey; C Boshoff
Journal:  Br J Cancer       Date:  2007-05-15       Impact factor: 7.640

View more
  10 in total

1.  The role of CXCR2 chemokine receptors in the oral squamous cell carcinoma.

Authors:  Juliana Romanini; Tânia R Mielcke; Paulo C Leal; Cláudia P Figueiredo; João B Calixto; Fernanda B Morrone; Eraldo L Batista; Maria M Campos
Journal:  Invest New Drugs       Date:  2011-06-14       Impact factor: 3.850

2.  Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer.

Authors:  Jingdong Zhang; Anthony Gill; Bryn Atmore; Amber Johns; Leigh Delbridge; Raymond Lai; Todd McMullen
Journal:  Int J Clin Exp Pathol       Date:  2011-04-28

3.  Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer.

Authors:  Meng Wang; Bao-Gang Liu; Zhao-Yang Yang; Xuan Hong; Gong-Yan Chen
Journal:  Exp Ther Med       Date:  2012-03-12       Impact factor: 2.447

4.  Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level.

Authors:  Joanna Waligórska-Stachura; Nadia Sawicka-Gutaj; Maciej Zabel; Mirosław Andrusiewicz; Paweł Gut; Agata Czarnywojtek; Marek Ruchała
Journal:  Oncol Lett       Date:  2017-02-10       Impact factor: 2.967

5.  Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules.

Authors:  Kristine Ducena; Arturs Abols; Janis Vilmanis; Zenons Narbuts; Juris Tārs; Diana Andrējeva; Aija Linē; Valdis Pīrāgs
Journal:  Thyroid Res       Date:  2011-06-27

6.  CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer.

Authors:  Lichao Sun; Yipeng Wang; Hebao Yuan; Joseph Burnett; Jian Pan; Zhihua Yang; Yuliang Ran; Ila Myers; Duxin Sun
Journal:  J Cancer       Date:  2016-06-18       Impact factor: 4.207

7.  An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis.

Authors:  Monika Lamba Saini; Caroline Bouzin; Birgit Weynand; Etienne Marbaix
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

8.  Survivin delta Ex3 overexpression in thyroid malignancies.

Authors:  Joanna Waligórska-Stachura; Mirosław Andrusiewicz; Nadia Sawicka-Gutaj; Maciej Biczysko; Anna Jankowska; Marta Kubiczak; Agata Czarnywojtek; Elżbieta Wrotkowska; Marek Ruchała
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

Review 9.  The twisted survivin connection to angiogenesis.

Authors:  C Sanhueza; S Wehinger; J Castillo Bennett; M Valenzuela; G I Owen; A F G Quest
Journal:  Mol Cancer       Date:  2015-11-19       Impact factor: 27.401

10.  Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients.

Authors:  Franziska Büscheck; Mariam Sulimankhil; Nathaniel Melling; Doris Höflmayer; Claudia Hube-Magg; Ronald Simon; Cosima Göbel; Andrea Hinsch; Sören Weidemann; Jacob R Izbicki; Frank Jacobsen; Tim Mandelkow; Niclas C Blessin; Christina Möller-Koop; Florian Lutz; Florian Viehweger; Katharina Möller; Guido Sauter; Maximillian Lennartz; Eike Burandt; Patrick Lebok; Sarah Minner; Sarah Bonk; Hartwig Huland; Markus Graefen; Thorsten Schlomm; Christoph Fraune
Journal:  Cancer Med       Date:  2020-01-01       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.